JCM | Free Full-Text | Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2-Breast Cancer—A Retrospective Analysis of Consecutive Patients Data
Overall survival of metronomic capecitabine and best supportive care... | Download Scientific Diagram
Safety and efficacy study of oral metronomic capecitabine combined with pyrotinib in HER2-positive metastatic breast cancer: A phase II trial - The Breast
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
Metronomic chemotherapy in mbc | PPT
Frontiers | Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
Metronomic capecitabine maintenance extends DFS in triple-negative breast cancer
Metronomic capecitabine as second-line treatment in hepatocellular carcinoma after sorafenib failure - ScienceDirect
Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients' T cell ferroptosis
Total Health | VuMedi
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
Metronomic capecitabine showed no significant myelosuppression. A and... | Download Scientific Diagram
Metronomic chemotherapy in breast cancer | Semantic Scholar
A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancer,Thoracic Cancer - X-MOL
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
Camrelizumab and metronomic capecitabine for patients with treatment-refractory solid tumors (McCREST trial) | Future Oncology
Metronomic capecitabine inhibits liver transplant rejection in rats by triggering recipients' T cell ferroptosis
Low-Dose Metronomic Capecitabine (Xeloda) for Treatment ofMetastatic Cholangiocarcinoma : Case Reports and Review of the Literature | Semantic Scholar
Metronomic Chemotherapy for Triple-Negative Breast Cancer
Clinical overview of metronomic chemotherapy in breast cancer | Nature Reviews Clinical Oncology
ATS BSHSR on X: "#Metronomic #capecitabine as adjuvant therapy in #locoregionally advanced #nasopharyngeal #carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial https://t.co/rDGiLM9sOB https://t.co/69Tdf9JAfY" / X
Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis
PDF) A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer
JCI Insight - Metronomic capecitabine as an immune modulator in glioblastoma patients reduces myeloid-derived suppressor cells
PDF) Metronomic capecitabine as maintenance treatment after first line induction with XELOX for metastatic colorectal cancer patients
Cancers | Free Full-Text | Metronomic Chemotherapy
Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial - The Lancet
